At a glance
ClinicalIndex Comparison RecordN/ACompleted· 24 enrolled
Drug / intervention
Cochlear Nucleus CI532device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Implantation With the Cochlear Nucleus® CI532 Implant - Early Experience Study
In Brief
A clinical study evaluating Cochlear Nucleus CI532 for Sensorineural Hearing Loss, Bilateral. Completed, enrolled 24 participants across 6 sites.
Detailed Summary
To evaluate performance outcomes in patients implanted with the Cochlear Nucleus CI532 electrode array.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSensorineural Hearing Loss, Bilateral
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedApr 2016
Enrollment StartMay 2016
Primary CompletionJun 2017
Study CompletionSep 2017
TodayJul 2026
First PostedApr 29, 2016
Enrollment StartMay 1, 2016
Primary CompletionJun 1, 2017
Study CompletionSep 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 10.2 years ago
Interventions
Cochlear Nucleus CI532device
cochlear implantation